Home | Recruitment

Recruiting

Trials by recruitment status

Public Title Date of registration Sponsor
Treatment for maxillary cysts 30/05/2018 SSA
Nimotuzumab-pancreatic cancer-adults-Phase IV. 30/04/2017 CIM
Safety and effectiveness of SURFACEN® combined with the conventional therapy, in the treatment of ARDS in pediatrics. National extension 29/09/2017 CENSA
Heberon Alfa R in COVID-19 29/05/2020 RPeredaGLEZ
Predictor of response with CIMAvax EGF© in NSCLC Phase III 29/01/2016 CIM
Racotumomab,Nimotuzumab or Docetaxel in the treatment of the advanced non-small cell lung cancer. 26/05/2014 CIM
SURFACEN in ARDS. Adults. Phase IV 24/06/2015 CENSA
Itolizumab (T1h) combined with insulin in patients with Type I Diabetes Mellitus 23/12/2016 CIM
Phase II / III. Nimotuzumab in patients with triple-negative breast cancer. 23/05/2014 CIM
DENIS Study 22/10/2018 CIGB
Interferon Combination in basal cell carcinoma (InCarbacel-IV study) 22/08/2013 CIGB
VIDA study 22/06/2020 CIGB
Evaluation of the synergistic effect of sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study 22/05/2020 FINLAY
VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2 22/05/2020 FINLAY
NAcGM3/VSSP-aids-patients drug resistant to antiretroviral treatment-Phase I-II 22/04/2016 CIM
Totally Laparoscopic Hysterectomy with Single-Port Access. Validation of a new technique in Cuba. 22/04/2014 CNCMA
Pneumococcal conjugate vaccination among Warao children 2013-06-14 SAIB
Pharmacokinetics of the Intralesional administration of rhEGF (doses: 75 µg and 225 µg) in advance Diabetic Foot Ulcers 2013-02-08 CIGB
Nimotuzumab in tumors of head and neck .Phase IV 2013-02-01 CIMAB
Sublingual immunotherapy with VALERGEN-Asthma-Children-Phase II 2012-04-02 BIOCEN